The Patent Finder

Adamas Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Adamas Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.

Back to Adamas Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,741,343Method of Administering Amantadine Prior to a Sleep Period
now held by Adamas Pharma, LLC
In force
 · High confidence
In forceHigh confidence
US 9,867,791Method of administering amantadine prior to a sleep period
now held by Adamas Pharma, LLC
In force
 · High confidence
In forceHigh confidence
US 9,867,792Method of administering amantadine prior to a sleep period
now held by Adamas Pharma, LLC
In force
 · Medium confidence
In forceMedium confidence
US 9,867,793Method of administering amantadine prior to a sleep period
now held by Adamas Pharma, LLC
In force
 · High confidence
In forceHigh confidence
US 9,877,933Method of administering amantadine prior to a sleep period
now held by Adamas Pharma, LLC
In force
 · High confidence
In forceHigh confidence
US 10,154,971Methods of Administering Amantadine
now held by Adamas Pharma, LLC
In force
 · High confidence
In forceHigh confidence
US 12,501,953Activewear Garment with Enhanced Traction
now held by LZRD Tech, Inc.
In force
 · High confidence
In forceHigh confidence
US 8,168,209Method and Composition for Administering an Nmda Receptor Antagonist to a Subject
Term ended
Term ended Jul 18, 2026 · High confidence
Term endedTerm ended Jul 18, 2026High confidence
US 8,796,337Composition and Method for Treating Neurological Disease
Term ended
Term ended Nov 23, 2025 · High confidence
Term endedTerm ended Nov 23, 2025High confidence
US 8,889,740Composition and Method for Treating Neurological Disease
Term ended
Ended no later than Nov 23, 2025 · Medium confidence
Term endedEnded no later than Nov 23, 2025Medium confidence
10 of 92 records shown.
Pro members see all 92.
Pro members: see all 92 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited